SHENZHEN SALUBRIS PHARMACEUTICALS
Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a comprehensive pharmaceutical company that integrates pharmaceutical products research and development, production and business sales, founded in 1998 and headquartered in Shenzhen, China.
SHENZHEN SALUBRIS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Status:
Active
Contact:
0755-83867888
Email Addresses:
[email protected]
Total Funding:
1.78 B CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content IIS IIS 7 China Telecom Tencent QQ Mail CNZZ
Similar Organizations
Accellix
Accellix is an assay delivery platform
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Qilu Pharmaceutical
Qilu Pharmaceutical is a large and comprehensive pharmaceutical company
SeQuent Scientific
SeQuent Scientific Limited is an India-based integrated pharmaceutical company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
The Carlyle Group
The Carlyle Group investment in Post-IPO Equity - Shenzhen Salubris Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-07 | SalubrisBio | Shenzhen Salubris Pharmaceuticals investment in Corporate Round - SalubrisBio | 32 M USD |
| 2019-06-13 | Mercator MedSystems | Shenzhen Salubris Pharmaceuticals investment in Series D - Mercator MedSystems | 14.33 M USD |
| 2018-12-04 | Viracta Therapeutics | Shenzhen Salubris Pharmaceuticals investment in Corporate Round - Viracta Therapeutics | 10 M USD |
| 2018-01-22 | KingstronBio | Shenzhen Salubris Pharmaceuticals investment in Series B - KingstronBio | 125 M CNY |
| 2018-01-16 | Jinjiang Electronics | Shenzhen Salubris Pharmaceuticals investment in Corporate Round - Jinjiang Electronics | N/A |
| 2017-08-17 | GO Therapeutics | Shenzhen Salubris Pharmaceuticals investment in Funding Round - GO Therapeutics | 5 M USD |
| 2016-12-23 | Zhongke Jiankang Wang | Shenzhen Salubris Pharmaceuticals investment in Angel Round - Zhongke Jiankang Wang | 3 M CNY |
More informations about "Shenzhen Salubris Pharmaceuticals"
Shenzhen Salubris Pharmaceuticals Co., Ltd.
WeChat Official Friendship link. National Health Commission of the People's Republic of China; State Drug Administration; Shenzhen Municipal Market Supervision Administration (Shenzhen …See details»
Salubris Pharmaceuticals - Wikipedia
Shenzhen Salubris Pharmaceuticals (Chinese: 深圳信立泰药业; pinyin: Shēnzhèn Xìnlìtài Yàoyè; SZSE: 002294) is a Chinese pharmaceutical company.. Founded in November 1998 and …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shenzhen Salubris Pharmaceuticals Co., Ltd. join us CN. Home page; About Us Profile Affiliates/Subsidiaries Development History Quality Management Contact Us Legal Statement …See details»
Salubris Pharmaceuticals - LinkedIn
Salubris Pharmaceuticals | 3,141 followers on LinkedIn. Salubris is a global integrated pharmaceutical group dedicated to the research, development, manufacture, marketing, distribution, and ...See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Investor Hotline Lian People: Yang Jianfeng Tel:(0755)-83867888 (Select investor relations according to the voice prompt) Pass true: (0755)-83867338 E-mail:[email protected] Land …See details»
Shenzhen Salubris Pharmaceuticals - Crunchbase
Contact Email [email protected] Phone Number 0755-83867888 Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a comprehensive pharmaceutical company that …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd | LinkedIn
Founded in 1998 and listed on the Shenzhen Stock Exchange (stock code: 002294) ,Shenzhen Salubris Pharmaceuticals Co., Ltd is an innovation-driven pharmaceutical company based in China and ...See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd. (China) - EMIS
Nov 24, 2024 Salubris, founded in 1998, is a global integratedpharmaceutical group dedicated to the research, development,manufacture, marketing, distribution, and service ofprofessional …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd. - xinlitai.cn
Shenzhen Salubris Pharmaceuticals Co., Ltd. join us CN. Home page; About Us Profile Affiliates/Subsidiaries Development History Quality Management Contact Us Legal Statement …See details»
Shenzhen Salubris Pharmaceutical Co., Ltd - Carlyle
Founded in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE: 002294) is a comprehensive pharmaceutical company that integrates pharmaceutical products research and development, …See details»
Carlyle to acquire 5% stake in Salubris, a leading …
Sep 1, 2020 About Salubris Founded in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE: 002294) is a comprehensive pharmaceutical …See details»
Shenzhen Salubris Pharmaceuticals Co Ltd - Google
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd. ESG Risk Rating
Feb 27, 2023 Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular …See details»
Teriparatide biosimilar - Shenzhen Salubris Pharmaceuticals
Jul 5, 2021 A biosimilar of teriparatide administered subcutaneously for injection (1-34) once weekly is being developed by Shenzhen Salubris Pharmaceuticals for the Teriparatide …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd.
SalubrisBio was founded in August 2016 as a wholly-owned subsidiary of the China-based pharmaceutical company Shenzhen Salubris Pharmaceuticals Co. Ltd. Headquartered in the …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shenzhen Salubris Pharmaceuticals Co., Ltd. join us CN. Home page; About Us Profile Affiliates/Subsidiaries Development History Quality Management Contact Us Legal Statement …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
Find the latest Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Shenzhen Salubris Pharmaceuticals - Funding, Financials, Valuation ...
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number ... Lead Investors . Sep 1, 2020: Post-IPO Equity - Shenzhen Salubris …See details»
Shenzhen Salubris Pharmaceuticals sees highest filings and grants ...
Shenzhen Salubris Pharmaceuticals saw the highest growth of 3.99% in patent filings and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings …See details»
Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE ... - Simply …
2 days ago Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) price-to-earnings (or "P/E") ratio of 63.5x might make it look like a strong sell right now compared to the market in …See details»